Deciduous Therapeutics Announces Appointments to the Board, SAB, and Advisor Roles

SAN FRANCISCO: SAN FRANCISCO, Oct. 27, 2021 /PRNewswire/ -- Deciduous Therapeutics, an early stage immune therapy start-up, announced today the appointment of an independent board member, additional Scientific Advisory Board members, and company advisors. Mr. Robert Forrester joins Deciduous as an Independent Board Member. He will be joining Robin Mansukhani,...

Click to view original post